rs11558748
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000267996.11(TPM1):c.*31G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00083 ( 1 hom. )
Consequence
TPM1
ENST00000267996.11 3_prime_UTR
ENST00000267996.11 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0320
Publications
13 publications found
Genes affected
TPM1 (HGNC:12010): (tropomyosin 1) This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]
TPM1 Gene-Disease associations (from GenCC):
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- dilated cardiomyopathy 1YInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-63071203-G-A is Benign according to our data. Variant chr15-63071203-G-A is described in ClinVar as Benign. ClinVar VariationId is 257060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0854 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TPM1 | NR_176337.1 | n.1045G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | ||||
| TPM1 | NR_176338.1 | n.2265G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | ||||
| TPM1 | NR_176340.1 | n.1064G>A | non_coding_transcript_exon_variant | Exon 10 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TPM1 | ENST00000267996.11 | c.*31G>A | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000267996.7 | ||||
| TPM1 | ENST00000358278.7 | c.*31G>A | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000351022.3 | ||||
| TPM1 | ENST00000404484.9 | c.*31G>A | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000384315.4 |
Frequencies
GnomAD3 genomes AF: 0.00252 AC: 22AN: 8726Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
22
AN:
8726
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00657 AC: 69AN: 10502 AF XY: 0.00501 show subpopulations
GnomAD2 exomes
AF:
AC:
69
AN:
10502
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000827 AC: 188AN: 227210Hom.: 1 Cov.: 0 AF XY: 0.000782 AC XY: 91AN XY: 116424 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
188
AN:
227210
Hom.:
Cov.:
0
AF XY:
AC XY:
91
AN XY:
116424
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
10
AN:
6210
American (AMR)
AF:
AC:
0
AN:
6522
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
4952
East Asian (EAS)
AF:
AC:
8
AN:
2510
South Asian (SAS)
AF:
AC:
24
AN:
18638
European-Finnish (FIN)
AF:
AC:
5
AN:
11446
Middle Eastern (MID)
AF:
AC:
3
AN:
988
European-Non Finnish (NFE)
AF:
AC:
127
AN:
166324
Other (OTH)
AF:
AC:
11
AN:
9620
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.395
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00263 AC: 23AN: 8736Hom.: 0 Cov.: 0 AF XY: 0.00264 AC XY: 11AN XY: 4168 show subpopulations
GnomAD4 genome
AF:
AC:
23
AN:
8736
Hom.:
Cov.:
0
AF XY:
AC XY:
11
AN XY:
4168
show subpopulations
African (AFR)
AF:
AC:
9
AN:
4006
American (AMR)
AF:
AC:
2
AN:
492
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
218
East Asian (EAS)
AF:
AC:
4
AN:
16
South Asian (SAS)
AF:
AC:
0
AN:
92
European-Finnish (FIN)
AF:
AC:
0
AN:
634
Middle Eastern (MID)
AF:
AC:
0
AN:
26
European-Non Finnish (NFE)
AF:
AC:
8
AN:
3092
Other (OTH)
AF:
AC:
0
AN:
120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:2
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.